EMBRACE-OBS: Single-Site Observational Registry of Patient-Reported Outcomes Following MMA Embolization for Migraine
Eligible age
18–64 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
EMBRACE-OBS is the first phase of the EMBRACE research program. This single-site observational registry accesses and analyzes patient-reported outcome data already collected through routine clinical care from adults with migraine who have undergone or plan to undergo middle meningeal artery (MMA) embolization. The study describes changes in headache frequency, headache severity, medication use, migraine-related disability, quality of life, and reported adverse events over time without influencing clinical care.
Sponsor: Cortex Neurovascular
You may qualify if…
- ✓ Adults aged 18 to 64 years
- ✓ Diagnosis of migraine
- ✓ Have undergone or plan to undergo middle meningeal artery (MMA) embolization as part of routine clinical care, independent of study participation
- ✓ Able and willing to provide informed consent
- ✓ Able to read and understand English sufficiently to complete informed consent and patient-reported outcome assessments
You may not qualify if…
- ✕ Age under 18 years
- ✕ Pregnancy at the time of enrollment
- ✕ Inability to provide informed consent
- ✕ Inability to read and understand English sufficiently to complete informed consent and patient-reported outcome assessments
- ✕ Insufficient clinical or patient-reported outcome data for the planned analyses
Where it's recruiting
Tacoma
Source: ClinicalTrials.gov · NCT07652034 · last updated 2026-09-23